Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Caplin Point Laboratories Limited ( (IN:CAPLIPOINT) ) is now available.
Caplin Point Laboratories Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The company also appointed Mr. Ashok Partheeban and Mr. Vivek Partheeban as Additional Directors and Vice-Chairmen, with Mr. Vivek Partheeban relinquishing his position as Chief Operating Officer. Additionally, Dr. K C John was appointed as a Non-Executive Independent Director for a five-year term.
More about Caplin Point Laboratories Limited
Average Trading Volume: 6,399
Technical Sentiment Signal: Buy
Current Market Cap: 152B INR
Learn more about CAPLIPOINT stock on TipRanks’ Stock Analysis page.